| Literature DB >> 18465031 |
Guang Yang1, Yaping Gao, Jiannan Feng, Yong Huang, Shaohua Li, Yu Liu, Chuan Liu, Ming Fan, Beifen Shen, Ningsheng Shao.
Abstract
In Staphylococcus aureus, the target of RNAIII activating protein (TRAP) is a membrane-associated protein whose C-terminus can be used as a vaccine to provide protection against staphylococcal infection. Here, we show for the first time by surface plasmon resonance and enzyme-linked immunosorbent assay that TRAP can specifically bind lysozyme and lysostaphin through its C-terminus (amino acids 155-167) and enhance lysozomal activities in vitro. It was also found that the traP mutant strain is more resistant to lysostaphin than wild-type. Our previous data showed that the C-terminus of TRAP might be extracellular. So our results suggested that the C-terminus of TRAP could act as the specific targeting protein of the lysozyme/lysostaphin on the S. aureus cell wall and the biological significance of the interaction might be to facilitate lysozyme/lysostaphin-mediated cell lysis.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18465031 DOI: 10.1111/j.1745-7270.2008.00415.x
Source DB: PubMed Journal: Acta Biochim Biophys Sin (Shanghai) ISSN: 1672-9145 Impact factor: 3.848